Prostate Cancer UK Professionals

Close-up of an individual using a laptop, focusing on the face and hand. The person is wearing a black shirt with pins, including a crown and a red cross.

🗣️ YOUR FEEDBACK MATTERS

Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations.

Please complete this form to help us understand how best to support you and your patients ➡️ bit.ly/4pGzzyH

Infographic by Prostate Cancer UK illustrating the current diagnostic pathway for prostate cancer, including steps from PSA blood test, MRI scan, to targeted transperineal biopsy, followed by diagnosis.

Screening takes time but early diagnosis can’t wait.

Keep supporting men at risk and stay informed with our latest guidance, education and clinical resources.

Sign up to our health professional e-newsletter ➡️ bit.ly/2VktI7b

Group photo of various health professionals in front of a building, everyone is smiling.

Ready to lead impactful change? Apply now to be a part of our award-winning 18-month flagship programme.

🌟Apply now: bit.ly/46I5Fn9

I'm excited to take part in this discussion because it offers an inclusive space to openly explore ideas, share challenges and opportunities in research career progression, and work together to drive meaningful change. Dr Uzoamaka Okoli, University College London.

📣 We’re looking forward to the discussion session at From Ideas to Innovation, which will explore Equity in Research Career Progression.

🙏We’re grateful to our research community for sharing their insights and experiences.

⬇️ Check out the full agenda.

prostatecanceruk.org/research/for...

Image featuring portraits of Professors Hashim Ahmed and Mark Emberton, co-leads of the TRANSFORM trial. The text discusses their hopes of revolutionising prostate cancer diagnosis and treatment through the trial. Both are dressed professionally, with Ahmed in surgical attire and Emberton in a suit.

🥼 Meet Prof Hashim Ahmed and Prof Mark Emberton, researchers and clinicians dedicated to improving the way we diagnose men with prostate cancer.

Find out more ➡️ bit.ly/3xSHfYS

Image of Dr. Bunmi Olajide, a GP (primary care clinician), wearing glasses and a suit, with a quote about the importance of early detection of prostate cancer to improve treatment outcomes.

🥼 Meet Dr Bunmi Olajide, a GP dedicated to improving cancer care and raising awareness of Black men’s higher risk of prostate cancer.

Learn more ➡️ bit.ly/4ip3ysp

Close-up of an individual using a laptop, focusing on the face and hand. The person is wearing a black shirt with pins, including a crown and a red cross.

🗣️ YOUR FEEDBACK MATTERS

Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations.

Please complete this form to help us understand how best to support you and your patients ➡️ bit.ly/4pGzzyH

Scientific Paper published in Physica Medica, titled: Sensitivity analysis of dose-response model parameters for the bladder in prostate cancer radiotherapy. Written by Puri et al.

Could dose–response model parameters influence identification of bladder regions vulnerable to radiotherapy-induced toxicity?

A team led by Dr Tanuj Puri, Prof Marcel van Herk & Dr Alan McWilliam @manchester.ac.uk share new findings in Physica Medica.

Grab a ☕ & read: doi.org/10.1016/j.ej...

TRANSFORM trial The £42 million TRANSFORM trial, the biggest prostate cancer screening trial in 20 years, could save the lives of thousands of men each year.

While the NSC has recommended screening only for men with BRCA gene variations, this isn’t the end of the story.

Our ongoing research, including TRANSFORM, will provide the evidence needed to expand screening safely in the future.

Find out more ➡️ bit.ly/3xSHfYS

Close-up of an individual using a laptop, focusing on the face and hand. The person is wearing a black shirt with pins, including a crown and a red cross.

🗣️ YOUR FEEDBACK MATTERS

Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations.

Please complete this form to help us understand how best to support you and your patients ➡️ bit.ly/4pGzzyH

Infographic by Prostate Cancer UK illustrating prostate cancer risk factors. It shows that 1 in 8 men will get prostate cancer, with higher risks for individuals over 50, those with a family history, Black individuals, and those with BRCA gene variations.

Friday’s NSC recommendation is a step toward targeted prostate cancer screening for men with BRCA gene variations.

However, many men at higher risk are being missed.

Read more about the recent announcement here➡️ bit.ly/4ip3ysp

Man in a white shirt wearing a Prostate Cancer UK pin badge, speaking on a phone, with text 'Our new Black Men's One-to-One Support Service'.

Our new Black Men’s One-to-One Support Service connects Black men affected by prostate cancer to a volunteer who truly understands their experience.

🩵 Please signpost men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer.

Thank you to all the researchers, clinicians and health professionals who continue to drive progress in early prostate cancer diagnosis 🩵

Your work is helping shape the evidence and care that will save more men’s lives.

Read more about it here👉 buff.ly/OojAs47

🚨 BREAKING NEWS

The UK NSC has announced support for targeted prostate cancer screening for men with BRCA gene variations. A step forward in earlier detection for men at highest risk.

Read our co-signed statement here ➡️ buff.ly/nXIirI0

Picture of Professor Hashim Ahmed, Chief Investigator of the TRANSFORM trial.

The November edition of Research News is here! Discover more about:

💙 TRANSFORM - Screening Trial Open!
🧑 UK Prostate Cancer Clinical Research Strategy Group
🤝 An exciting upcoming meeting.
💰 Funding opportunities.

📖 Read it here: buff.ly/WLlHpLg

How does IGF-1 contribute to #ProstateCancer immune evasion?

In dedication to the late Professor Valentine Macaulay, a team including Professor Ian Mills from @ndsurgicalsci.bsky.social @ox.ac.uk detail novel findings in Scientific Reports.

Grab a ☕ and read: doi.org/10.1038/s415...

Are you someone living with or beyond cancer? Researchers at the University of Aberdeen are inviting you to participate in a questionnaire about taking care of your health. More info and questionnaire here: iahs.qualtrics.com/jfe/form/SV_...

👩‍⚕️ Are you a healthcare professional from Scotland, Wales, or Northern Ireland?

Apply to our Clinical Champions Programme to drive real improvements in prostate cancer care with expert support.

Find out more 👉 bit.ly/46I5Fn9

Man in a white shirt wearing a Prostate Cancer UK pin badge, speaking on a phone, with text 'Our new Black Men's One-to-One Support Service'.

Our new Black Men’s One-to-One Support Service connects Black men affected by prostate cancer to a volunteer who truly understands their experience.

🩵 Please signpost men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer.

Scientific Paper published in Annals of Oncology, titled: Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems data. Written by Jones et al.

Could zoledronic acid lower fracture risk in advanced hormone-sensitive #ProstateCancer?

@asachdeva.bsky.social & team @manchester.ac.uk, funded by our Movember FASTMAN Centre of Excellence, share their analysis in Annals of Oncology.

Grab a ☕ & read: doi.org/10.1016/j.an...

Are you a healthcare professional who'd like to understand the latest evidence on the role of genomics in risk prediction, targeted screening and personalised treatment?

👇Register now to join us at @roysocmed.bsky.social and be part of shaping genomics-informed #ProstateCancer care.

Could CAR-T cells carrying collagen targeted IL-12 be a safe therapy for #ProstateCancer?

A team including Prostate Cancer UK fellow @Ko1ssk.bsky.social & Jun Ishihara @imperialcollegeldn.bsky.social share new results in @natbiomedeng.nature.com.

Grab a ☕ and read:
doi.org/10.1038/s415...

With huge thanks to Professor Emma Hall and Claire Snowden @icr-ctsu.bsky.social for generously sharing their expertise in this free to attend webinar.

Careers in Research Webinar. Clinical Trials Units: Elevating Research for Real-World Impact. Tuesday 13 January 2026, 1-2pm (online). Professor Emma Hall and Claire Snowdon. The Institute of Cancer Research - Clinical Trials and Statistics Unit (ICR-CTSU).

📢Careers in Research Webinar📢

🤔Got a great idea, but not sure how to turn it into a clinical trial?

📉Curious about careers in trials – stats, methods, data?

Register to explore how partnering with a CTSU can support researchers at every stage 👇

events.teams.microsoft.com/event/2b9a0b...

Calling all Clinician and AHPs 👨‍⚕️ 👩‍⚕️

Apply for our free 18-month flagship Clinical Champions Programme. Become a leader in transforming care and support for men impacted by prostate cancer.

Apply today 👉 bit.ly/46I5Fn9

Man in a white shirt wearing a Prostate Cancer UK pin badge, speaking on a phone, with text 'Our new Black Men's One-to-One Support Service'.

Our new Black Men’s One-to-One Support Service connects Black men affected by prostate cancer to a volunteer who truly understands their experience.

🩵 Please signpost men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer.

Scientific Paper published in Clinical Cancer Research, titled: Integration of Dose Surface Maps and Genetic Data Identifies the Lower Posterior Rectum as a Key Region for Toxicity after Prostate Cancer Radiotherapy. Written by Bouzaki et al.

Could genetic information help personalise radiotherapy to reduce rectal toxicity?

A team led by Dr Alan McWilliam and Artemis Bouzaki at @manchester.ac.uk report exciting new findings in Clinical Cancer Research.

Grab a ☕ and read: doi.org/10.1158/1078...

Members of the Clinical Research Strategy Group at the Prostate Cancer UK headquarters

Next CRSG meeting:
📅Fri 17 Apr 2026,
🚩London.

Details 👇
🔗 prostatecanceruk.org/research/for...

🧵[5/6]

💡 Got a new trial idea to improve outcomes for men with prostate cancer?

Use our form and submit your proposal

Deadline: 4pm, Fri 13 Feb

Applicants are encouraged to present their ideas and take part in the discussion at the next CRSG meeting.

prostatecanceruk.org/research/for...

🧵[4/6]

🌱 Early-career clinical researchers — your opportunity is here!

Apply for one of two CRSG observer roles to learn from leaders, connect nationally & grow your research career in prostate cancer.

Deadline: 4pm, Fri 16 Jan